INTERFERON ALPHA MEDIATED REMODELING OF THE BONE MARROW STEM CELL VASCULAR NICHE

EHA Library, Áine M Prendergast, 135176

MAJOR BLEEDING IN PATIENTS ON TREATMENT WITH NOAC OR VKA IN REAL-LIFE: CLINICAL PRESENTATION, MANAGEMENT AND OUTCOME

EHA Library, Laura Franco, 135172

THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG FOR ADVANCED MDS OR AML AND SEVERE THROMBOCYTOPENIA: 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 ASPIRE STUDY

EHA Library, Moshe Mittelman, 135163

INCREASED REACTIVE OXYGEN SPECIES AND EXHAUSTION OF QUIESCENT CD34-POSITIVE BONE MARROW CELLS MAY CONTRIBUTE TO POOR GRAFT FUNCTION AFTER ALLOTRANSPLANT

EHA Library, Yuan Kong, 135158

RUXOLITINIB PROVES SUPERIOR TO BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA (PV) AND A NONPALPABLE SPLEEN: RESULTS FROM THE PHASE IIIB RESPONSE-2 STUDY

EHA Library, Francesco Passamonti, 135145

ADJUSTMENT OF THERAPY FOR HODGKIN LYMPHOMA BASED ON INTERIM PET IS BENEFICIAL AND RADIOTHERAPY MAY BE SUBSTITUTED WITH CHEMOTHERAPY IN PATIENTS WITH NEGATIVE INTERIM STUDY: FINAL RESULTS OF H2 TRIAL

EHA Library, Eldad Dann, 135140

WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Sara Bringhen, 135135

DISTINCT HOMOTYPIC B-CELL RECEPTOR INTERACTIONS SHAPE THE OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Paolo Ghia, 135149

SINGLE-CELL PROFILING OF HUMAN MEGAKARYOCYTE-ERYTHROID PROGENITORS IDENTIFIES DISTINCT MEGAKARYOCYTE AND ERYTHROID DIFFERENTIATION PATHWAYS

EHA Library, Beth Psaila, 135175

DECODING THE RISK OF THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS

EHA Library, Darko Antic, 135171

HIGH SYSTEMIC IRON LEVEL IS A RISK FACTOR FOR CARDIOVASCULAR DISEASE

EHA Library, Francesca Vinchi, 135167

CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WITH OR WITHOUT PRETREATMENT THROMBOCYTOPENIA

EHA Library, Guillermo Garcia-Manero, 135162

ACUTE MYELOID LEUKEMIA (AML) PATIENTS CURED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION GENERATE TUMOR-SPECIFIC CYTOTOXIC ANTIBODIES THAT KILL AML BLASTS

EHA Library, Mette Hazenberg, 135157

HNRNP K: AN ONCOGENE AND TUMOR SUPPRESSOR, TWO DISCRETE PATHS TO AML THROUGH ON GENE

EHA Library, Miguel Gallardo, 135153

INCREASED RISK OF SECOND MALIGNANCIES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2009 ? A POPULATION-BASED COHORT STUDY OF 9,379 PATIENTS

EHA Library, Anna Ravn Landtblom, 135144

LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE HODGKIN LYMPHOMA (HL): UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7, HD8, HD10 AND HD11 TRIALS

EHA Library, Paul Bröckelmann, 135139

IMPROVED EFFICACY AFTER INCORPORATING AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) INTO KRD TREATMENT WITH CARFILZOMIB (CFZ), LENALIDOMIDE (LEN), AND DEXAMETHASONE (DEX) IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Andrzej J. Jakubowiak, 135134

HUMAN HEMATOPOIETIC STEM CELL DIFFERENTIATION FOLLOWS A CONTINUOUS WADDINGTON-LIKE LANDSCAPE

EHA Library, Marieke Essers, 135174

ETHNICITY AND THE EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM: A POPULATION-BASED STUDY

EHA Library, Alejandro Lazo-Langner, 135170

GENETIC LOSS OF ERYTHROID TFR2 STRONGLY AFFECTS THE THALASSEMIC PHENOTYPE IN MICE

EHA Library, Antonella Nai, 135166

ARCADE (20090160): A PHASE 3 RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN THE TREATMENT OF ANEMIA IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Uwe Platzbecker, 135161

NBEA: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELL IN VIVO REPOPULATION

EHA Library, Miguel Ganuza Fernandez, 135156

FREQUENT RECURRING MUTATIONS DISRUPT THE ANTI-PROLIFERATIVE FUNCTION OF ZBTB7AIN ACUTE MYELOID LEUKEMIA WITH T(8;21) TRANSLOCATION

EHA Library, Luise Hartmann, 135152

INTEGRATIVE ANALYSIS OF GENE MUTATIONS AND CHROMOSOMAL ABNORMALITIES BY NEXT-GENERATION SEQUENCING AND FISH IN HEMATOPOIETIC PROGENITORS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Hernandez Sanchez, 135148

OUTCOMES OF 121 PREGNANCIES IN PATIENTS WITH POLYCYTHEMIA VERA (PV)

EHA Library, Martin Griesshammer, 135143

BASELINE TOTAL METABOLIC VOLUME (TMTV) PREDICTS THE OUTCOME OF PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (HL) ENROLLED IN THE AHL2011 LYSA TRIAL

EHA Library, Olivier CASASNOVAS, 135138

CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03)

EHA Library, Xavier Leleu, 135133

Q&A and Panel Discussion

EHA Library, Faculty / Presenters, 141358

Antidotes for novel oral anticoagulants

EHA Library, Jean Marie Connors, 137041

HTS for IG and TR repertoire studies in lymphoproliferative diseases

EHA Library, Kostas Stamatopoulos, 137037

When and how to test for heparin-induced thrombocytopenia (HIT) antibodies?

EHA Library, Yves Gruel, 137040

HTS for minimal residual disease in lymphoid malignancies

EHA Library, Monika Brüggemann, 137036

Bioinformatic strategies for HTS data analysis

EHA Library, Nikos DARZENTAS, 137035

Genomics and NGS in thrombosis

EHA Library, Pieter Reitsma, 137039

Introduction: Strategies for HTS of IG-TR genes: Possibilities and limitations

EHA Library, Anton Langerak, 137034

Drug induced immune thrombocytopenia

EHA Library, Tamam Bakchoul, 137030

Inherited thrombocytopenias predisposing to hematological malignancies

EHA Library, Hana Raslova, 137029

Panel Discussion

EHA Library, Faculty / Presenters, 137627

Predictors of bleeding in thrombocytopenic patients

EHA Library, Paola Gresele, 137028

New treatment approaches in Hodgkin lymphoma in 2016

EHA Library, Igor Aurer, 136643

Risk adapted treatment of early stage HL

EHA Library, Marc Andre, 136642

Pathogenesis of HL

EHA Library, Ralf Küppers, 136641

Treatment of the elderly CLL patients

EHA Library, Barbara Eichhorst, 136640

Prognostic and predictive factors in the era of new targeted therapies

EHA Library, Davide Rossi, 136639

B-cell receptor structure and function in CLL

EHA Library, Francesco Forconi, 136638

Evidence based transfusion medicine for coagulopathy in patients with CLD

EHA Library, Pratima Chowdary, 136637

Transfusion management of coagulation abnormalities in CLD: From bench to bedside

EHA Library, Armando Tripodi, 136636

Hemostasis and thrombosis in patients with liver disease

EHA Library, Ton Lisman, 136635

Primary CNS Lymphoma

EHA Library, Andres Jose Maria Ferreri, 136634

Histiocytic disorders of children and adults

EHA Library, Maarten Egeler, 136633

Systemic Mastocytosis for the Hematologist

EHA Library, Hanneke Kluin-Nelemans, 136632

Immunological predictors of successful treatment discontinuation

EHA Library, Satu Mustjoki, 136631

What have we learned from stopping TKI treatment in CML?

EHA Library, Susanne Saussele, 136630

Modeling CML blast crisis

EHA Library, Brian Huntly, 136629

Primary cutaneous B-cell lymphomas

EHA Library, Rein Willemze, 136628

Intravascular Large B-cell Lymphoma

EHA Library, Maurilio Ponzoni, 136627

NF-kappaB cooperating events in mature B cell derived malignancies

EHA Library, Dinis Calado, 136626

Smoldering MM

EHA Library, Maria Victoria Mateos, 136625

Pathophysiology and diagnosis of MM bone disease

EHA Library, Evangelos Terpos, 136624

Molecular architecture of MM

EHA Library, Brian Walker, 136623

IDENTIFICATION OF THE GENOMIC AND TRANSCRIPTOMIC CHANGES CORRELATED WITH THE EX VIVO RESISTANCE TO DAUNORUBICIN AND DOXORUBICIN IN PEDIATRIC ACUTE LEUKEMIAS

EHA Library, Joanna Laskowska, 132394

INFANT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA SHOWS CHARACTERISTIC GENETIC FEATURES COMPARED TO CHILDHOOD CASES

EHA Library, Jessica Hoell, 132393

IDELALISIB SENSITIVITY AND MECHANISMS OF DISEASE PROGRESSION IN RELAPSED TCF3-PBX1 ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Samuli Eldfors, 132392

CHARACTERISATION OF JAK3 KINASE DOMAIN MUTANTS

EHA Library, Sandrine Degryse, 132391

THE WEE1 INHIBITION DEEPLY SENSITIZES ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINES AND PRIMARY CELLS TO THE CYTOTOXIC EFFECT OF DIFFERENT ANTINEOPLASTIC COMPOUNDS

EHA Library, Andrea Ghelli Luserna Di Rora, 132390

DYNAMICS OF EARLY RESPONSE TO TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IS ASSOCIATED WITH GENE DEFECTS

EHA Library, Agata Pastorczak, 132389

ROLE OF G9A AND EPIGENETIC CHANGES IN LEUKEMIA CELL MIGRATION AND THEIR REGULATION BY VLA4 INTEGRIN.

EHA Library, Javier Redondo Munoz, 132388

SLOWER EARLY RESPONSE TO TREATMENT AND DISTINCT EXPRESSION PROFILE OF CHILDHOOD HIGH HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKAEMIA WITH DNA INDEX <1.16

EHA Library, Jan Zuna, 132395

DIFFERENT PROGNOSTIC ROLE OF RECURRENT COPY NUMBER ABERRATIONS IN B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITHOUT RECURRENT FUSION GENES IN 3 CONSECUTIVE AGE COHORTS

EHA Library, Monica Messina, 132396

CALCINEURIN COMPLEX ISOLATED FROM T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS IDENTIFIES NEW SIGNALING PATHWAYS WHOSE INHIBITION SYNERGIZE WITH CALCINEURIN INHIBITION TO PROMOTE T-ALL CELL DEATH

EHA Library, Erich Piovan, 132397

OVEREXPRESSION OF PTP4A3 IN ETV6-RUNX1 ACUTE LEUKEMIA

EHA Library, Toni Grönroos, 132398

DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Francesco ALBANO, 132399

ABNORMAL EXPRESSION OF THE CYSTEINE AND GLYCINE-RICH PROTEIN 2 GENE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Shu-Juan Wang, 132400

IL7R OVEREXPRESSION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PROGNOSTIC IMPLICATIONS IN B-LINEAGE ALL WITHOUT RECURRENT FUSION TRANSCRIPTS

EHA Library, Valentina Gianfelici, 132401

NEGATIVE PRE TRANSPLANT MINIMAL RESIDUAL DISEASE, ASSESSED BY FLOW CYTOMETRY, IMPROVES OUTCOME IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA, ESPECIALLY IF CLEARENCE IS ACHIEVED EARLY DURING INDUCTION

EHA Library, Massimiliano Gambella, 132402

MOLECULAR DETECTION OF ALL IN THE PERIPHERAL BLOOD IS MORE SENSITIVE THAN FLOW CYTOMETRIC ANALYSIS OF THE BONE MARROW IN PATIENTS WITH TREATMENT-RELATED HYPOCELLULARITY

EHA Library, Ilan Kirsch, 132403

PATTERN OF CNS RELAPSE IN ACUTE LYMPHOBLASTIC LEUKEMIA BCR-ABL POSITIVE, THE IMPORTANCE OF CHARACTERIZATION OF ABL1 MUTATIONS IN CEREBROSPINAL FLUID.

EHA Library, Joaquin Martinez-Lopez, 132414

DE-ESCALATION OF INTENSITY DID NOT AFFECT THE LONG-TERM OUTCOME NEITHER IN T-ALL NOR IN BCP-ALL IF NON-INTERRUPTIVE TREATMENT IS APPLIED: RESULTS OF THE RUSSIAN ALL STUDY GROUP.

EHA Library, Elena Parovichnikova, 132404

SERIAL MONITORING OF BCR-ABL BY REAL-TIME POLYMERASE CHAIN REACTION IN NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH IMATINIB

EHA Library, Sungnam Lim, 132405

KPT-8602 IS A SECOND-GENERATION XPO1 INHIBITOR WITH IMPROVED IN VIVO TOLERABILITY AND POTENT IN VIVO ACTIVITY AGAINST ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jolien De Bie, 132406

DETAILED CHARACTERIZATION OF LAIP PROFILE AND HETEROGENEITY AT TIME OF DIAGNOSIS PREDICTS MINIMAL RESIDUAL DISEASE IN B-CELL PRECURSOR ALL

EHA Library, Signe Modvig, 132407

PHASE I STUDY OF MOXETUMOMAB PASUDOTOX IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Farhad Ravandi, 132408

INTENSIVE VS. SEMI-INTENSIVE CHEMOTHERAPY IN OLDER ADULTS (55-65 YR) WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Josep-Maria Ribera, 132409

FLOW CYTOMETRY OF CEREBROSPINAL FLUID IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AT DIAGNOSIS AND RELAPSE

EHA Library, Maria Gabelli, 132410

USE OF VOXEL-BASED MORPHOMETRY TO DETECT CEREBRAL VOLUMES ABNORMALITIES IN LONG TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Rosanna Parasole, 132411

HYPER-CVAD COMPARED TO BFM-LIKE CHEMOTHERAPY FOR THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA. A RETROSPECTIVE SINGLE CENTER ANALYSIS

EHA Library, Jean El Cheikh, 132412

BFM REGIMEN OFFERS SIMILAR EVENT FREE SURVIVAL COMPARED TO HYPERCVAD BUT WITH LESS TOXICITY IN ADOLESCENTS AND YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Arturo Vega, 132413

LPS STIMULATION INDUCES ROS FORMATION, APOPTOSIS, DNA DAMAGE AND OXIDATION OF CYSTEINE RESIDUES IN FLT3-ITD POSITIVE CELL LINES RESULTING IN FLT3-TYROSINE KINASE INHIBITOR RESISTANCE

EHA Library, Christian Mueller, 132426

TYROSINE KINASE INHIBITORS IN PHILADELPHIA-CHROMOSOME POSITIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN REAL CLINICAL PRACTICE

EHA Library, Frantisek Folber, 132425

DOES TIMING OF CENTRAL VENOUS LINE REPLACEMENT MATTER DURING INDUCTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?

EHA Library, Eda Ataseven, 132424

HEMATOPOIETIC STEM CELLS CAN BE SEPARATED FROM LEUKEMIC CELLS IN A SUBGROUP OF ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Christoph Lutz, 132423

LONG-TERM OUTCOME OF RELAPSED ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CONTINUOUS IMATINIB PLUS COMBINATION CHEMOTHERAPY

EHA Library, Sungnam Lim, 132422

NOVEL DYNAMIN2 MUTATION IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zheng Ge, 132421

MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMİA (ALL): PRE AND POST TRANSPLANT

EHA Library, Pinar Ataca, 132420

RISK FACTORS IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A COLLABORATIVE STUDY OF THE BIOLOGICAL COMMITTEE OF THE LEUKEMIA GROUP OF THE SPANISH HEMATOLOGY AND ONCOLOGY PEDIATRIC SOCIETY

EHA Library, Mireia Camós, 132419

CHARACTERISTICS OF PONATINIB THERAPY FOR PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) PATIENTS IN REAL-WORLD CLINICAL PRACTICE COMPARED TO THE PACE TRIAL

EHA Library, Michael J. Mauro, 132418

LOW EXPRESSION OF LYMPHOID ENHANCER-BINDING FACTOR-1 (LEF1) ASSOCIATES WITH POOR PROGNOSTIC FACTORS IN PEDIATRIC ACUTE LEUKEMIA

EHA Library, Mireia Camós, 132417

COMBINED BLINATUMOMAB + DASATINIB/IBRUTINIB THERAPY OF RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS – ANTILEUKEMIC EFFECT ON THE T-HELPER AND T-REGULATORY CELLS REDUCTION BACKGROUND.

EHA Library, Andrey Sokolov, 132416

PROGNOSTIC IMPACT OF COPY NUMBER ALTERATIONS IN A SERIES OF PEDIATRIC PATIENTS WITH DE NOVO B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A SINGLE CENTER

EHA Library, Mireia Camós, 132415

IMPROVING NELARABINE EFFICACY IN REFRACTORY/RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY TARGETING ABERRANT PI3K/MTOR SIGNALING

EHA Library, Francesca Chiarini, 132387